PlainRecalls
FDA Drug Moderate Class II Ongoing

3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.

Reported: December 24, 2025 Initiated: October 31, 2025 #D-0230-2026

Product Description

3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.

Reason for Recall

Defective container: cracked/broken cartridges

Details

Units Affected
5,825
Distribution
U.S.A. Nationwide
Location
Cambridge

Frequently Asked Questions

What product was recalled?
3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.. Recalled by Novocol Pharmaceutical of Canada, Inc.. Units affected: 5,825.
Why was this product recalled?
Defective container: cracked/broken cartridges
Which agency issued this recall?
This recall was issued by the FDA Drug on December 24, 2025. Severity: Moderate. Recall number: D-0230-2026.